Thus, we hypothesize that the observed effects on EGFR and PCa cell properties upon DHRS7 downregulation are either due to the lack of the formation of a yet-unknown tumor suppressor or to the abolished inactivation of a promoter although ligand-independent effects mediated through protein–protein interactions cannot currently be excluded. The gene discussed is DHRS7; the disease is neoplasm.